Merck MRK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Merck , NewLink Ebola vaccine appears safe, effective in new studies

      Headlines

      Wed, 1 Apr 2015

      NEW YORK, April 1 (Reuters) - Early-stage trials of an experimental Ebola vaccine, two in the United States and four in Africa and Europe, have found that it appears to be safe and triggered robust production of Ebola-fighting antibodies, scientists reported on Wednesday.

    2. Health Care: 3 Picks in a More Expensive Sector

      Headlines

      Wed, 1 Apr 2015

      still look undervalued, including Merck MRK , Actavis ACT, and Baxter BAX ..... are well-positioned for growth. Merck MRK Despite some upcoming patent loses, we believe the market undervalues Merck 's strong pipeline, led by cancer

    3. Liquidity

      Headlines

      Tue, 31 Mar 2015

      Merck MRK announced on Thursday that the New Jersey ..... purchases. We believe the ruling bodes well for Merck , and we are not changing our fair value ..... to a class-action suit. Furthermore, Merck can spread the cases out over several years

    4. BRIEF-EU agency recommends approval of Gardasil 9 vaccine, other drugs

      Headlines

      Fri, 27 Mar 2015

      March 27 (Reuters) - European Medicines Agency: * EU medicines agency says recommends approval of Merck 's Gardasil 9

    5. New Cancer Drugs: First Movers Will Win

      Video Reports

      Fri, 27 Mar 2015

      first mover in this space. They are followed closely by Merck ( MRK ). And we think, longer term, both Roche (ROG) and ..... early-stage assets. Of the companies I just mentioned, Merck is currently the most undervalued. It is currently trading

      Merck MRK found at 1:34

      currently the first mover in this space. They are followed closely by Merck ( MRK ). And we think, longer term, both Roche (ROG) and [TICKER:AZN] AstraZeneca (AZN) are also well positioned. On the biotech side, we thing Insight has some attractive early-stage assets. Of the companies I just mentioned, Merck is currently the most undervalued. It is currently trading at about a 15% discount to our fair value estimate. It represents an
    6. BRIEF-Ablynx extends ion channel research collaboration with Merck

      Headlines

      Thu, 26 Mar 2015

      * Announces extension of ion channel research collaboration with Merck & Co., Inc.

    7. Guinea starts testing Merck vaccine in Ebola hotspots

      Headlines

      Wed, 25 Mar 2015

      CONAKRY/DAKAR, March 25 (Reuters) - Guinea started testing an experimental Ebola vaccine from Merck and NewLink Genetics on affected communities this week, in a move officials hope will accelerate the end of an epidemic first detected a year ago.

    8. Merck increases share buyback program by $10 bln

      Headlines

      Tue, 24 Mar 2015

      March 24 (Reuters) - Drugmaker Merck Inc said its board authorized an additional share repurchase of up to $10 billion of the company's common stock.

    9. UPDATE 1- Merck says melanoma drug meets goal; study halted

      Headlines

      Tue, 24 Mar 2015

      March 24 (Reuters) - Merck & Co Inc said on Tuesday that it would stop a large study of its Keytruda melanoma treatment early because an independent monitoring

    10. Study of Merck melanoma drug halted after survival prolonged

      Headlines

      Tue, 24 Mar 2015

      March 24 (Reuters) - Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring

    « Prev12345Next »
    Content Partners